Apimeds Pharmaceuticals US, Inc.
APUS
$2.20
-$0.07-3.08%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.71M | -1.50M | -1.39M | -1.65M | -1.42M |
| Total Depreciation and Amortization | 200.00 | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.01M | 128.80K | 117.70K | 103.20K | 70.60K |
| Change in Net Operating Assets | -1.97M | 876.40K | 538.80K | 567.60K | 292.00K |
| Cash from Operations | -3.67M | -490.80K | -733.60K | -974.60K | -1.06M |
| Capital Expenditure | -13.40K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.40K | -- | -- | -- | -- |
| Total Debt Issued | 493.90K | 593.70K | 326.50K | 195.00K | 100.00K |
| Total Debt Repaid | -93.80K | -- | -- | 0.00 | -31.90K |
| Issuance of Common Stock | 11.95M | -- | -- | 55.00K | 1.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.35M | 593.70K | 326.50K | 250.00K | 1.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.67M | 102.90K | -407.10K | -724.60K | 62.80K |